Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genelux (GNLX) Shares Outstanding (2022 - 2025)

Genelux has reported Shares Outstanding over the past 4 years, most recently at $38.1 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $38.1 million for Q4 2025, up 9.82% from a year ago — trailing twelve months through Dec 2025 was $38.1 million (up 9.82% YoY), and the annual figure for FY2025 was $38.1 million, up 9.82%.
  • Shares Outstanding for Q4 2025 was $38.1 million at Genelux, roughly flat from $38.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding for GNLX hit a ceiling of $38.1 million in Q4 2025 and a floor of -$433333.0 in Q1 2023.
  • Median Shares Outstanding over the past 4 years was $27.0 million (2024), compared with a mean of $24.1 million.
  • Biggest five-year swings in Shares Outstanding: soared 8064.46% in 2024 and later increased 9.41% in 2025.
  • Genelux's Shares Outstanding stood at $22.1 million in 2022, then increased by 21.25% to $26.8 million in 2023, then grew by 29.64% to $34.7 million in 2024, then grew by 9.82% to $38.1 million in 2025.
  • The last three reported values for Shares Outstanding were $38.1 million (Q4 2025), $38.0 million (Q3 2025), and $37.8 million (Q2 2025) per Business Quant data.